FTRE — Fortrea Holdings Inc.

Nasdaq · Health Care · Health Care Providers & Services · CIK 1965040 ·
Last close
$13.22
Market Cap
$1.25B
52W High
$16.20
52W Low
$8.55
ADV30
1,409,183
Next earnings
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 636,500,000 123,600,000 3,300,000 -23,600,000 2,683,400,000 147,500,000 2,157,500,000
Dec 2025 660,500,000 131,100,000 8,800,000 -32,500,000 2,715,700,000 174,600,000 2,152,200,000
Sep 2025 701,300,000 122,700,000 -3,700,000 -15,900,000 2,742,100,000 131,300,000 2,161,300,000
Jun 2025 710,300,000 133,500,000 -10,900,000 -374,900,000 2,835,100,000 81,200,000 2,245,900,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$220,700,000
Investing CF
$-9,700,000
Financing CF
$-164,700,000
CapEx
$-30,300,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-4.91
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,406,800,000
Inventory
Receivables
$619,600,000
ST Investments
EBIT TTM
$-359,100,000
Pretax Income TTM
$-447,300,000
Interest Exp TTM
$88,200,000
Analysts
11

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,708,600,064
EBITDA
$69,900,000
Free Cash Flow
$285,612,512
Enterprise Value
$2,221,711,872
Total Cash
$147,500,000
Total Debt
$1,118,599,936
Shares Out
94,584,730
Trailing EPS
$-4.81
Book Value
$6.05
ROE
-64.5%
ROA
-0.1%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,723,400,000 -30,600,000 -986,200,000 2,715,700,000 2,152,200,000 113,500,000
Dec 2024 2,696,400,000 -111,800,000 -328,500,000 3,579,200,000 2,216,800,000 262,800,000
Dec 2023 2,842,500,000 53,200,000 -25,200,000 4,332,600,000 2,618,500,000 168,400,000
Dec 2022 2,837,000,000 222,800,000 186,200,000 4,287,900,000 945,300,000 82,700,000

TTM Snapshot

Revenues TTM
$2,138,500,000
NetIncome TTM
$-91,800,000
OpCashFlow TTM
$0
Assets (Latest)
$3,579,200,000
Forward EPS
$1.08

Peers — same industry

TickerNameMarket CapLastDaily %
TDOC Teladoc Health, Inc. $1.19B $6.59
PNTG Pennant Group, Inc. $1.18B $33.92
ARDT Ardent Health, Inc. $1.33B $9.29
HCSG HEALTHCARE SERVICES GROUP INC $1.39B $20.32
CDNA CareDx, Inc. $1.11B $21.54

News headlines (Yahoo Finance, 1h cache)

Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1
2026-05-25 17:55 · Yahoo
Fortrea’s Q1 Earnings Call: Our Top 5 Analyst Questions
2026-05-15 13:32 · Yahoo
Does Fortrea (FTRE) Shrinking Losses With Flat Sales Clarify Its Path to Sustainable Profitability?
2026-05-06 20:18 · Yahoo
Is Now An Opportune Moment To Examine Fortrea Holdings Inc. (NASDAQ:FTRE)?
2026-05-06 10:22 · Yahoo
Fortrea Q1 Earnings Call Highlights
2026-05-05 18:34 · Yahoo
Fortrea Holdings Inc. Q1 2026 Earnings Call Summary
2026-05-05 16:51 · Yahoo
Fortrea (FTRE) Q1 2026 Earnings Transcript
2026-05-05 15:46 · Yahoo
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates
2026-05-05 11:25 · Yahoo
Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars
2026-05-05 10:31 · Yahoo
Fortrea Reports First Quarter 2026 Results
2026-05-05 10:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.